ETF Managers Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $1.24M | Buy |
+8,475
| New | +$1.24M | 0.04% | 180 |
|
|
2022
Q4 | – | Sell |
-20,154
| Closed | -$2.69M | – | 611 |
|
|
2022
Q3 | $2.69M | Sell |
20,154
-58,812
| -74% | -$7.84M | 0.09% | 135 |
|
|
2022
Q2 | $12.3M | Sell |
78,966
-52,601
| -40% | -$8.22M | 0.36% | 66 |
|
|
2022
Q1 | $20.7M | Sell |
131,567
-83,960
| -39% | -$13.2M | 0.42% | 62 |
|
|
2021
Q4 | $27.6M | Sell |
215,527
-33,749
| -14% | -$4.33M | 0.55% | 67 |
|
|
2021
Q3 | $32.8M | Sell |
249,276
-11,448
| -4% | -$1.51M | 0.62% | 61 |
|
|
2021
Q2 | $46.7M | Buy |
+260,724
| New | +$46.7M | 0.76% | 47 |
|
|
2019
Q2 | – | Sell |
-947
| Closed | -$135K | – | 618 |
|
|
2019
Q1 | $135K | Buy |
947
+66
| +7% | +$9.41K | 0.01% | 434 |
|
|
2018
Q4 | $109K | Buy |
881
+136
| +18% | +$16.8K | 0.01% | 456 |
|
|
2018
Q3 | $125K | Buy |
+745
| New | +$125K | ﹤0.01% | 364 |
|
|
2018
Q2 | – | Sell |
-483
| Closed | -$71K | – | 547 |
|
|
2018
Q1 | $71K | Buy |
483
+60
| +14% | +$8.82K | ﹤0.01% | 435 |
|
|
2017
Q4 | $58K | Buy |
423
+60
| +17% | +$8.23K | ﹤0.01% | 491 |
|
|
2017
Q3 | $53K | Buy |
363
+32
| +10% | +$4.67K | ﹤0.01% | 376 |
|
|
2017
Q2 | $51K | Buy |
+331
| New | +$51K | ﹤0.01% | 339 |
|
|
2016
Q1 | $31K | Buy |
+212
| New | +$31K | 0.02% | 323 |
|